Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |